Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 59.57M | 93.76M | 94.46M | 63.35M | 69.38M |
Gross Profit | 33.62M | 44.42M | 31.42M | 19.36M | 27.97M |
EBITDA | -27.06M | 5.14M | 6.78M | -2.98M | 6.32M |
Net Income | -36.16M | -3.12M | -1.55M | -10.41M | 132.00K |
Balance Sheet | |||||
Total Assets | 111.37M | 155.52M | 175.75M | 165.05M | 179.72M |
Cash, Cash Equivalents and Short-Term Investments | 6.29M | 11.56M | 18.25M | 31.82M | 41.35M |
Total Debt | 26.60M | 31.50M | 32.04M | 25.67M | 32.77M |
Total Liabilities | 50.70M | 60.20M | 69.23M | 54.62M | 60.85M |
Stockholders Equity | 60.66M | 95.32M | 106.52M | 110.44M | 118.86M |
Cash Flow | |||||
Free Cash Flow | -1.18M | -1.24M | -5.50M | -394.00K | -1.39M |
Operating Cash Flow | 4.28M | 1.91M | -1.61M | 3.28M | 3.39M |
Investing Cash Flow | -4.96M | -3.11M | -13.40M | -5.27M | -5.09M |
Financing Cash Flow | -4.18M | -2.19M | 1.60M | -8.06M | 13.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | $3.18B | 5.02 | -5.68% | 5.66% | 8.05% | -41.83% | |
46 Neutral | €33.69M | ― | -49.67% | ― | -31.33% | -393.01% | |
€248.65M | 116.41 | 0.50% | 2.56% | ― | ― | ||
€37.48M | 29.01 | 4.54% | ― | ― | ― | ||
70 Outperform | €63.15M | 10.79 | 2.86% | ― | ― | ||
€74.31M | ― | ― | ― | ― | |||
€64.34M | 133.17 | ― | ― | ― |
Eurotech S.p.A. has announced the availability of an information document concerning a capital increase transaction with its shareholder and related party, Emera S.r.l. This document, prepared in compliance with regulatory standards, includes opinions from the Related Parties Committee and Ambromobiliare S.p.A. The transaction underscores Eurotech’s strategic financial maneuvers to strengthen its market position and enhance its operational capabilities.
The most recent analyst rating on (IT:ETH) stock is a Hold with a EUR1.20 price target. To see the full list of analyst forecasts on Eurotech S.p.A. stock, see the IT:ETH Stock Forecast page.
Eurotech’s Board of Directors has approved a capital increase of 2.5 million Euros, reserved for its relative majority shareholder, Emera S.r.l. This move converts payments made by Emera in 2024 into share capital, strengthening Emera’s stake to approximately 24.725% of Eurotech’s share capital. The capital increase aims to enhance Eurotech’s financial position and market transparency, with the transaction being classified as a related party transaction due to Emera’s significant influence. The Board has ensured compliance with regulatory requirements and transparency by publishing relevant documents and opinions.
The most recent analyst rating on (IT:ETH) stock is a Hold with a EUR1.20 price target. To see the full list of analyst forecasts on Eurotech S.p.A. stock, see the IT:ETH Stock Forecast page.
Eurotech S.p.A. has appointed Dr. Massimo Milan as the new CEO, succeeding Dr. Paul Chawla, to lead the company through its next phase of transformation and relaunch after a challenging 2024. Dr. Milan brings extensive experience in leading high-tech industrial companies with international operations, and his expertise in business development and restructuring is expected to drive Eurotech’s sustainable growth and strengthen its market position.
The most recent analyst rating on (IT:ETH) stock is a Hold with a EUR0.80 price target. To see the full list of analyst forecasts on Eurotech S.p.A. stock, see the IT:ETH Stock Forecast page.
Eurotech S.p.A. has made available the minutes of its ordinary meeting held on April 28, 2025. This announcement underscores Eurotech’s commitment to transparency and communication with its stakeholders, reinforcing its position in the IoT and Edge Computing industry by keeping investors and partners informed about its corporate activities.
The most recent analyst rating on (IT:ETH) stock is a Hold with a EUR1.20 price target. To see the full list of analyst forecasts on Eurotech S.p.A. stock, see the IT:ETH Stock Forecast page.
Eurotech S.p.A. reported a 31% decline in revenues for the first quarter of 2025, attributed to a significant slowdown in order intake during the last quarter of 2024. Despite the revenue drop, the company saw a 29% increase in orders and improved its first margin by 90 basis points. Operating costs were reduced by €1.3 million, which helped mitigate the impact on EBITDA. The company faced challenges in the European market, particularly in Germany, due to macroeconomic factors and an industrial sector crisis. However, there was a positive shift in order intake, driven by the recovery in the ADAS business in Germany, the railway sector, and engineering services in Japan.
The most recent analyst rating on (IT:ETH) stock is a Hold with a EUR1.50 price target. To see the full list of analyst forecasts on Eurotech S.p.A. stock, see the IT:ETH Stock Forecast page.
Eurotech S.p.A.’s Ordinary Shareholders’ Meeting approved the financial statements for 2024, revealing a significant decline in revenues and an increased net loss compared to the previous year. The meeting also resulted in several key decisions, including the renewal of authorization for the purchase and disposal of treasury shares, approval of the remuneration policy, and a reduction in the number of board members, which reflects the company’s efforts to streamline operations amid financial challenges.
Eurotech S.p.A. has appointed Dr. Tiziana Olivieri as a new non-executive and independent director, following the resignation of Massimo Russo. This appointment aligns with the company’s proposal to reduce the number of directors and adhere to gender balance regulations. Dr. Olivieri will also serve as president of the related parties committee and a member of the nomination and remuneration committee. Her appointment is set to be confirmed at the upcoming Shareholders’ Meeting.
Eurotech S.p.A. has made its report on remuneration policy and compensation publicly available, adhering to legislative requirements. This announcement reflects the company’s commitment to transparency and regulatory compliance, which may strengthen its trustworthiness and appeal to investors and stakeholders.